Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(5):594–599. doi: 10.1038/bjc.1997.431

Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.

K Tanaka 1, H Inoue 1, H Miki 1, E Masuda 1, M Kitaichi 1, K Komaki 1, T Uyama 1, Y Monden 1
PMCID: PMC2228017  PMID: 9303357

Abstract

We have demonstrated the expression of thyrotropin receptor (TSH-R) in thyroid neoplasms (13 adenomas, 21 papillary carcinomas, two follicular carcinomas) and adjacent normal thyroid using the monoclonal antibody against human TSH-R and have also demonstrated a relationship between prognostic scores and the expression of TSH-R. Among the adenomas, eight showed an intensity similar to that of normal thyroid and five showed a higher intensity than normal. Two tumours exhibited heterogeneous distribution of TSH-R. Among the papillary carcinomas, seven showed similar intensity to normal tissue and four showed higher intensity and ten showed weaker intensity. Eight tumours showed heterogeneous distribution of the stain. Among the follicular carcinomas, one showed similar intensity to normal tissue and the other exhibited weaker intensity. Both cases showed homogeneous distribution of TSH-R. The adenomas never showed a weaker intensity than normal thyroid, but various intensities of TSH-R occurred in differentiated carcinomas. There was no significant relationship between the clinical data and the signal intensity in the adenomas. Among the papillary carcinomas, however, the group with weaker intensity had significantly poorer prognostic scores than the other two groups. Thus, we assume that low TSH-R may be expressed by the clinically high-risk group of patients with papillary thyroid carcinoma.

Full text

PDF
594

Images in this article

595Figure 1
on p.595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe Y., Ichikawa Y., Muraki T., Ito K., Homma M. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. J Clin Endocrinol Metab. 1981 Jan;52(1):23–28. doi: 10.1210/jcem-52-1-23. [DOI] [PubMed] [Google Scholar]
  2. Bergé-Lefranc J. L., Cartouzou G., De Micco C., Fragu P., Lissitzky S. Quantification of thyroglobulin messenger RNA by in situ hybridization in differentiated thyroid cancers. Difference between well-differentiated and moderately differentiated histologic types. Cancer. 1985 Jul 15;56(2):345–350. doi: 10.1002/1097-0142(19850715)56:2<345::aid-cncr2820560224>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  3. Berlingieri M. T., Akamizu T., Fusco A., Grieco M., Colletta G., Cirafici A. M., Ikuyama S., Kohn L. D., Vecchio G. Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: correlation between transformation, loss of thyrotropin-dependent growth, and loss of thyrotropin receptor gene expression. Biochem Biophys Res Commun. 1990 Nov 30;173(1):172–178. doi: 10.1016/s0006-291x(05)81037-x. [DOI] [PubMed] [Google Scholar]
  4. Byar D. P., Green S. B., Dor P., Williams E. D., Colon J., van Gilse H. A., Mayer M., Sylvester R. J., van Glabbeke M. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979 Aug;15(8):1033–1041. doi: 10.1016/0014-2964(79)90291-3. [DOI] [PubMed] [Google Scholar]
  5. CRILE G., Jr, HAZARD J. B. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg. 1953 Jul;138(1):33–38. doi: 10.1097/00000658-195307000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cady B., Cohn K., Rossi R. L., Sedgwick C. E., Meissner W. A., Werber J., Gelman R. S. The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma. Surgery. 1983 Dec;94(6):978–983. [PubMed] [Google Scholar]
  7. Cady B., Sedgwick C. E., Meissner W. A., Wool M. S., Salzman F. A., Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer. 1979 Mar;43(3):810–820. doi: 10.1002/1097-0142(197903)43:3<810::aid-cncr2820430306>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  8. Clark O. H., Castner B. J. Thyrotropin "receptors" in normal and neoplastic human thyroid tissue. Surgery. 1979 Jun;85(6):624–632. [PubMed] [Google Scholar]
  9. DeGroot L. J. Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer. Am J Med. 1994 Dec;97(6):499–500. doi: 10.1016/0002-9343(94)90342-5. [DOI] [PubMed] [Google Scholar]
  10. Franssila K. O. Prognosis in thyroid carcinoma. Cancer. 1975 Sep;36(3):1138–1146. doi: 10.1002/1097-0142(197509)36:3<1138::aid-cncr2820360346>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  11. Hay I. D., Bergstralh E. J., Goellner J. R., Ebersold J. R., Grant C. S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993 Dec;114(6):1050–1058. [PubMed] [Google Scholar]
  12. Kimura H., Yamashita S., Namba H., Usa T., Fujiyama K., Tsuruta M., Yokoyama N., Izumi M., Nagataki S. Impairment of the TSH signal transduction system in human thyroid carcinoma cells. Exp Cell Res. 1992 Dec;203(2):402–406. doi: 10.1016/0014-4827(92)90014-y. [DOI] [PubMed] [Google Scholar]
  13. Loosfelt H., Pichon C., Jolivet A., Misrahi M., Caillou B., Jamous M., Vannier B., Milgrom E. Two-subunit structure of the human thyrotropin receptor. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3765–3769. doi: 10.1073/pnas.89.9.3765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mizukami Y., Hashimoto T., Nonomura A., Michigishi T., Nakamura S., Noguchi M., Matsukawa S. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. J Clin Endocrinol Metab. 1994 Aug;79(2):616–619. doi: 10.1210/jcem.79.2.8045985. [DOI] [PubMed] [Google Scholar]
  15. Namba H., Yamashita S., Usa T., Kimura H., Yokoyama N., Izumi M., Nagataki S. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line. Endocrinology. 1993 Feb;132(2):839–845. doi: 10.1210/endo.132.2.8381075. [DOI] [PubMed] [Google Scholar]
  16. Ohta K., Endo T., Onaya T. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. Biochem Biophys Res Commun. 1991 Feb 14;174(3):1148–1153. doi: 10.1016/0006-291x(91)91540-s. [DOI] [PubMed] [Google Scholar]
  17. Schlumberger M., Charbord P., Fragu P., Lumbroso J., Parmentier C., Tubiana M. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab. 1980 Sep;51(3):513–519. doi: 10.1210/jcem-51-3-513. [DOI] [PubMed] [Google Scholar]
  18. Shi Y., Zou M., Farid N. R. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis. Clin Endocrinol (Oxf) 1993 Sep;39(3):269–274. doi: 10.1111/j.1365-2265.1993.tb02365.x. [DOI] [PubMed] [Google Scholar]
  19. Solomon B. L., Wartofsky L., Burman K. D. Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab. 1996 Jan;81(1):333–339. doi: 10.1210/jcem.81.1.8550774. [DOI] [PubMed] [Google Scholar]
  20. Takahashi H., Jiang N. S., Gorman C. A., Lee C. Y. Thyrotropin receptors in normal and pathological human thyroid tissues. J Clin Endocrinol Metab. 1978 Oct;47(4):870–876. doi: 10.1210/jcem-47-4-870. [DOI] [PubMed] [Google Scholar]
  21. Tanaka K., Inoue H., Miki H., Komaki K., Monden Y. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization. Clin Endocrinol (Oxf) 1996 Mar;44(3):259–267. [PubMed] [Google Scholar]
  22. Vassart G., Dumont J. E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev. 1992 Aug;13(3):596–611. doi: 10.1210/edrv-13-3-596. [DOI] [PubMed] [Google Scholar]
  23. Verschueren C. P., Rutteman G. R., Vos J. H., Van Dijk J. E., de Bruin T. W. Thyrotrophin receptors in normal and neoplastic (primary and metastatic) canine thyroid tissue. J Endocrinol. 1992 Mar;132(3):461–468. doi: 10.1677/joe.0.1320461. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES